Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DMAC - DiaMedica receives FDA clearance to initiate mid-stage DM199 trial for CKD

DMAC - DiaMedica receives FDA clearance to initiate mid-stage DM199 trial for CKD

DiaMedica Therapeutics Inc.
  • The FDA accepts DiaMedica Therapeutics' (NASDAQ:DMAC) Phase II clinical trial protocol for the treatment of Chronic Kidney Disease (CKD).
  • More news on: DiaMedica Therapeutics Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: DiaMedica Therapeutics Inc.
Stock Symbol: DMAC
Market: NASDAQ
Website: diamedica.com
Menu
DMAC DMAC Quote DMAC Short DMAC News DMAC Articles DMAC Message Board
Get DMAC Alerts

News, Short Squeeze, Breakout and More Instantly...